Clinical isolation and genomic characterization of Rheinheimera tangshanensis following ECMO decannulation
Frontiers in Medicine · 13.11.2026 · 13
DOI: 10.3389/fmed.2026.2014163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 13.11.2026. Verfasst von Siqi Zhou und 2 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Rheinheimera species are widely distributed environmental bacteria that are rarely encountered in clinical microbiology. Although occasional human infections caused by Rheinheimera have been reported, the clinical significance of Rheinheimera tangshanensis remains largely unknown. Here, we report the phenotypic and genomic characterization of a clinical isolate of R. tangshanensis recovered from an ECMO-associated wound. A bacterial isolate (strain D3610) was recovered from wound secretion collected at the thigh ECMO decannulation site of a critically ill postoperative patient. Species identification was performed using MALDI-TOF MS, 16S rRNA gene sequencing, phylogenetic analysis, and average nucleotide identity (ANI) analysis. Antimicrobial susceptibility testing was performed to characterize the resistance phenotype. Whole-genome sequencing was conducted to identify antimicrobial resistance determinants and virulence-associated genes. Genome-based analysis confirmed that strain D3610 belonged to R. tangshanensis . The isolate showed elevated minimum inhibitory concentrations (MICs) to multiple β-lactam antibiotics, including carbapenems and cephalosporins. Resistome analysis revealed that R. tangshanensis carries β-lactamase gene and several determinants associated with resistance-nodulation-division (RND)-type efflux pumps. Genomic screening also identified putative virulence-associated homologs involved in motility, chemotaxis, adhesion, biofilm formation, and stress adaptation. This study describes the first clinically relevant isolation and genomic characterization of R. tangshanensis . The findings highlight the potential of environmental Rheinheimera species to act as reservoirs of clinically important resistance determinants and suggest that rare environmental bacteria may become opportunistic pathogens in highly vulnerable patients.
Zitieren
APA
Zhou, S., Xiao, S., & Han, L. (2026). Clinical isolation and genomic characterization of Rheinheimera tangshanensis following ECMO decannulation. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.2014163
Vancouver
Zhou S, Xiao S, Han L. Clinical isolation and genomic characterization of Rheinheimera tangshanensis following ECMO decannulation. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.2014163
BibTeX
@article{Zhou2026,
author = {Zhou, Siqi and Xiao, Shuzhen and Han, Lizhong},
title = {Clinical isolation and genomic characterization of Rheinheimera tangshanensis following ECMO decannulation},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.2014163}
}
EUVIMED